Results
2295
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2295 companies
Gyre Therapeutics
Market Cap: US$696.2m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$8.22
7D
-19.3%
1Y
-24.4%
Nika Pharmaceuticals
Market Cap: US$667.1m
A pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.
NIKA
US$0.65
7D
0%
1Y
30.5%
Trevi Therapeutics
Market Cap: US$662.4m
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.
TRVI
US$6.32
7D
0.4%
1Y
147.6%
Anavex Life Sciences
Market Cap: US$645.4m
A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.
AVXL
US$7.84
7D
6.4%
1Y
90.3%
Arbutus Biopharma
Market Cap: US$643.5m
A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.
ABUS
US$3.45
7D
0%
1Y
3.3%
Evolus
Market Cap: US$642.8m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$9.96
7D
1.5%
1Y
-22.6%
KalVista Pharmaceuticals
Market Cap: US$642.3m
A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.
KALV
US$13.35
7D
19.0%
1Y
12.6%
AnaptysBio
Market Cap: US$642.3m
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
ANAB
US$23.52
7D
16.8%
1Y
-0.9%
Cogent Biosciences
Market Cap: US$639.2m
A biotechnology company, focuses on developing precision therapies for genetically defined diseases.
COGT
US$5.79
7D
18.6%
1Y
-34.2%
AbCellera Biologics
Market Cap: US$638.8m
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$2.31
7D
16.7%
1Y
-38.9%
RxSight
Market Cap: US$631.1m
A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.
RXST
US$15.81
7D
-1.2%
1Y
-72.3%
Fulgent Genetics
Market Cap: US$630.8m
Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
FLGT
US$20.67
7D
1.8%
1Y
-1.0%
Claritev
Market Cap: US$628.7m
Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
CTEV
US$37.59
7D
37.2%
1Y
99.5%
CeriBell
Market Cap: US$620.9m
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
CBLL
US$16.93
7D
-2.0%
1Y
n/a
Curaleaf Holdings
Market Cap: CA$848.2m
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$1.14
7D
-7.3%
1Y
-81.6%
Sionna Therapeutics
Market Cap: US$616.0m
A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).
SION
US$14.48
7D
10.7%
1Y
n/a
Tian'an Technology Group
Market Cap: US$614.5m
Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.
TANA.F
US$13.50
7D
3.8%
1Y
8,900.0%
Embecta
Market Cap: US$610.7m
A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.
EMBC
US$10.61
7D
-5.8%
1Y
-17.4%
ORIC Pharmaceuticals
Market Cap: US$602.1m
A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.
ORIC
US$8.40
7D
45.3%
1Y
-3.0%
Regulus Therapeutics
Market Cap: US$600.4m
A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.
RGLS
US$7.97
7D
0.8%
1Y
260.6%
Taysha Gene Therapies
Market Cap: US$597.8m
A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.
TSHA
US$2.78
7D
6.7%
1Y
-24.5%
Advanced Medical Solutions Group
Market Cap: UK£441.0m
Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.
AMS
UK£2.07
7D
4.5%
1Y
-2.1%
Keros Therapeutics
Market Cap: US$595.4m
A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.
KROS
US$14.95
7D
4.2%
1Y
-69.8%
Bicycle Therapeutics
Market Cap: US$592.1m
A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.
BCYC
US$8.30
7D
3.4%
1Y
-63.5%
Iovance Biotherapeutics
Market Cap: US$587.7m
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
IOVA
US$1.82
7D
5.2%
1Y
-77.5%
LifeMD
Market Cap: US$584.0m
Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
LFMD
US$12.65
7D
9.6%
1Y
68.0%
Integral Diagnostics
Market Cap: AU$900.8m
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.
IDX
AU$2.42
7D
1.7%
1Y
2.1%
Upstream Bio
Market Cap: US$573.4m
A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
UPB
US$10.84
7D
12.7%
1Y
n/a
Butterfly Network
Market Cap: US$571.2m
Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
BFLY
US$2.36
7D
-6.7%
1Y
155.3%
Elite Pharmaceuticals
Market Cap: US$570.7m
A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.
ELTP
US$0.54
7D
1.4%
1Y
226.7%
Xencor
Market Cap: US$569.4m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.
XNCR
US$8.58
7D
13.3%
1Y
-64.2%
Delcath Systems
Market Cap: US$567.7m
An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
DCTH
US$16.08
7D
-2.0%
1Y
149.3%
Mind Medicine (MindMed)
Market Cap: US$565.1m
A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.
MNMD
US$7.69
7D
7.7%
1Y
-6.8%
PolyNovo
Market Cap: AU$873.9m
Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.
PNV
AU$1.27
7D
-1.6%
1Y
-41.7%
Dianthus Therapeutics
Market Cap: US$563.8m
A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.
DNTH
US$17.59
7D
-1.9%
1Y
-19.1%
Talkspace
Market Cap: US$560.5m
Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.
TALK
US$3.41
7D
15.6%
1Y
32.2%